1 Top 10 New & Emerging Health Technology Watch List: 2014 Antimicrobial Copper Surfaces to Reduce Hospital-Acquired Infections in Intensive Care Settings Ex vivo Lung Perfusion Device to Preserve and Assess Donor Lungs Prior to Transplant Ipilimumab for Unresectable or Metastatic Melanoma Mitral Valve Clip for Degenerative Mitral Regurgitation Obinutuzumab (plus Chlorambucil) for Newly Diagnosed Chronic Lymphocytic Leukemia Remote Ischemic Conditioning (RIC) Device to Prevent Cardiac Ischemia and Infarction in Patients Undergoing Cardiac Surgery Retinal Implant to Improve Vision in Patients with Retinitis Pigmentosa Self-Expanding, Drug-Coated Stent for the Treatment of Peripheral Arterial Disease Trastuzumab Emtansine (T-DM1) for HER2-Positive Metastatic Breast Cancer Tympanostomy Tube Insertion Delivery System for Children With Chronic Ear Infections
2 Antimicrobial Copper Surfaces to Reduce Hospital-Acquired Infections in Intensive Care Settings Health care-associated infections (HAIs) infections that patients acquire while in health care settings are a concern, especially for patients in the intensive care unit (ICU). In Canada, approximately 200,000 patients acquire HAIs on a yearly basis, with an estimated mortality of 8,000 per year. Bacterial contamination on various surface areas in health care facilities can be a source of transmission to patients, health professionals, and visitors. Adequate control of hospital-acquired infections can reduce morbidity and mortality, and increase the quality of life of patients receiving health care. Regular touch surfaces are generally made of stainless steel, plastic, or other materials, and are cleaned regularly according to guidelines and policies. These policies outline the types of products to be used for cleaning, the frequency of cleaning, and describe how to clean specific surfaces. Factors that influence cleaning practices include: the type of activity conducted in the area (e.g., ICU) and its associated risk of infection, the frequency of contact with the touch surface, the vulnerability of patients, and the probability of contamination from bodily fluids. Antimicrobial copper surfaces that help prevent and control bacterial contamination, transmission, and rates of infection Touch surfaces made of antimicrobial copper and copper alloy (brasses and bronzes) appear to be a promising alternative that may improve the prevention and control of infection and, therefore, offer safer health care environments for patients. When incorporated on surface areas such as bedrails, handrails, door handles, work surfaces, intravenous (IV) poles, and washroom components, the natural antimicrobial properties of copper would reduce bacterial contamination, transmission, and rates of infection. The lower levels of bacteria on copper surfaces in an ICU setting have led to a reduction in rates of health care-acquired infection. This new technology, which is intended to deliver antibacterial activity in between regular cleaning intervals, is purported to have antibacterial properties that last the product s lifetime. It appears the antimicrobial copper surfaces achieve a 99.9% reduction in both gram-negative and gram-positive bacteria within two hours of exposure. Additionally, it appears the copper alloys are safe both for humans and the environment. Its effectiveness in decreasing infection rates in hospitals and other health care settings may also increase the quality of life for patients.
3 Ex vivo Lung Perfusion Device to Preserve and Assess Donor Lungs Prior to Transplant Lung transplantation is a treatment option for a variety of respiratory conditions, including chronic obstructive pulmonary disease, interstitial lung disease, cystic fibrosis, and idiopathic pulmonary hypertension. In Canada, the number of people on the waiting list for a lung transplant has doubled during the last decade, from 150 people to more than 300. Although 180 lung transplants are typically performed annually in Canada, more than 40 patients die each year while on the waiting list for transplantation. Successful lung transplantation depends on several factors throughout the process of organ donation, from preservation of the lung during transportation to transplantation into the recipient. Once the donor lungs have been removed, they are traditionally preserved by being flushed with a preservative solution and placed on ice; however, the longer the lung is kept on ice, the greater the risk of organ damage due to hypothermia and lack of oxygenated blood circulation. Deterioration of donor lungs can lead to impaired lung function, complications such as primary graft dysfunction, or death. It is estimated that 80% to 85% of donor lungs are unsuitable for transplantation. Portable warm blood perfusion system for lung preservation before transplantation A new portable lung-preservation system uses normothermic (warm) oxygenated blood to keep donor lungs functioning outside the body while they are being transported from donor to recipient. The donor lungs are removed and placed into a perfusion module chamber designed to maintain the warm temperature and humidity. This system provides a constant supply of oxygen and preservation solution that contains packed red blood cells. A wireless monitor allows clinicians to continuously assess the function of the lungs to ensure the organ is viable. The warm blood lung-perfusion system improves the condition of donor lungs by maintaining the circulation of oxygen and nutrients to the lung tissue. This system minimizes the organ damage commonly seen with cold storage methods. Continuous monitoring and quality assessment of the lungs can be conducted until transplantation. Compared with cold storage, early trial results have shown improved patient survival at six months and fewer lung-related complications. This technology has the potential to improve the quality of donor lungs. As a result, many lungs that previously would have been rejected for transplantation may be considered suitable. This could increase the number lungs available to patients currently on the waiting list for transplant.
4 Ipilimumab for Unresectable or Metastatic Melanoma Rates of skin cancer in both men and women are increasing worldwide. An estimated 6,000 Canadians were diagnosed with melanoma in 2013, and 1,050 Canadians will die from the disease. When diagnosed early, melanoma may be cured by surgical removal of the tumour. However, if the melanoma cannot be removed with surgery or the cancer has spread or metastasized, the disease progresses quickly; patients with advanced melanoma have a median survival time of less than one year. When surgery is not appropriate, melanoma treatment focuses on therapies to prevent tumour spread, shrink metastases, and relieve patients symptoms. Treatment options include radiation therapy, chemotherapy, or drug therapy using biological agents. In Canada, chemotherapy with dacarbazine, temozolomide, or carboplatin plus paclitaxel are commonly used, but advanced melanoma is an aggressive disease and chemotherapies have been largely ineffective in extending patients life expectancy. Due to the low effectiveness of currently available treatments for patients whose melanoma is not curable with surgery, there is no accepted standard of care. Ipilimumab immunotherapy for patients with previously untreated unresectable or metastatic melanoma Immunotherapy is a recent option in cancer treatment. Instead of targeting the tumour itself, immunotherapy works by stimulating the body s natural immune system to fight the cancer. Immunotherapy agents such as interferon alpha and interleukin-2 have been used in the treatment of advanced melanoma, but these treatments have low response rates with no improvement in overall survival. Ipilimumab is a human monoclonal antibody that has an innovative mode of action compared with other immunotherapy agents. Ipilimumab works by blocking cytotoxic T lymphocyte-associated antigen (CTLA-4) to increase the tumour-specific immune response. Ipilimumab is approved in Canada for the treatment of inoperable or metastatic melanoma in patients where other treatments have failed, or for patients who cannot tolerate other therapies for advanced disease. Ipilimumab is the first therapy to demonstrate an improvement in survival for advanced melanoma. In a study of patients who had tried previous therapies for metastatic melanoma, treatment with ipilimumab nearly doubled survival rates at both 1 year and at 18 months, compared with a glycoprotein vaccine. The survival benefit observed with ipilimumab may also occur in patients with previously untreated metastatic melanoma. Side effects are generally mild to moderate immune-related events. For patients with metastatic melanoma ipilimumab treatment is not associated with a significantly negative impact on quality of life.
5 Mitral Valve Clip for Degenerative Mitral Regurgitation Mitral regurgitation, also called mitral insufficiency, is the most common heart valve disorder, where the heart valve that separates the upper and lower chambers on the left side of the heart does not close properly. The condition causes a backward flow of the blood in the heart and may raise the risk of irregular heartbeat, stroke, and heart failure. Significant (moderate or severe) mitral regurgitation occurs in approximately 2% of the population and its frequency increases with age. If untreated, the condition can be debilitating and fatal. The choice of treatment depends on the symptoms, severity of the condition, and its effect on the heart s function. In milder cases of mitral regurgitation, the use of medication can help to ease disease symptoms. In more severe cases, however, heart surgery to repair or replace the valve is the treatment of choice. Although open heart surgery has a very good success rate, it may not be suitable for patients who are at high risk of developing surgical complications, such as patients who may be too ill or too frail to survive open heart surgery. A new catheter-based, less invasive approach to mitral heart valve repair The MitraClip device is a new catheter-based, less invasive approach to mitral valve repair that can provide an alternative option for patients with severe mitral regurgitation who are too high risk to undergo surgery. The device is inserted using a long, flexible, soft plastic tube (catheter) through a small incision in the groin area and delivered into the heart through the femoral (leg) vein. After positioning the clip in the region of the mitral valve, the catheter is removed. The procedure is performed under general anesthesia. In a catheter-based percutaneous intervention, the mitral valve is repaired without the need for an invasive surgical procedure. The existing scientific evidence suggests that this procedure can be a safer approach than open heart surgery, especially for high-risk patients. It can also be considered as a preferred option by the patients who seek a less invasive treatment option. The device allows the heart to pump blood more efficiently by improving valve closure. As a result, the procedure can relieve the symptoms of mitral regurgitation and improve quality of life. In the recent clinical studies, patients who underwent percutaneous mitral valve repair interventions experienced shorter recovery times and a shorter hospital stay (two to three days).
6 Obinutuzumab (Plus Chlorambucil) for Newly Diagnosed Chronic Lymphocytic Leukemia Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in Western countries, representing approximately 3% of all new cancer cases each year in Canada. Most patients with CLL are older than 70 years of age, and many present with coexisting medical conditions. There is no agreed standard treatment regimen for symptomatic CLL. Chemotherapy, considered the conventional therapy, involves the use of chemotherapy drugs that target and kill cancer cells. For previously untreated CLL patients who are in good health, aggressive chemotherapy with a combination of highly toxic drugs such as fludarabine, cyclophosphamide, and rituximab (FCR) has been shown to prolong patients overall survival; however, for patients with coexisting medical conditions, limited treatment options are available. The common choices include drugs such as chlorambucil (with or without rituximab), bendamustine (with or without rituximab), ofatumumab (only in clinical studies), or reduced doses of FCR. Combination therapy with obinutuzumab and chlorambucil, a new and effective option to treat newly diagnosed CLL patients with coexisting medical conditions For previously untreated patients with CLL who have coexisting medical conditions, obinutuzumab in combination with chlorambucil appears to be a more effective treatment compared with chlorambucil alone. The combination therapy demonstrates a large (84%) risk reduction in disease worsening or death. Obinutuzumab in combination with chlorambucil more than doubles the chance of living without disease progression in CLL patients. The common adverse events are reported to be generally manageable infusionrelated reactions. Obinutuzumab is a new anti-cancer drug that works by stimulating the body s immune system to attack cancer cells. This drug targets white blood cells (called B lymphocytes) that have a surface marker known as CD20. The combination of obinutuzumab and chlorambucil has shown promise as a superior treatment option for CLL patients with coexisting medical conditions who had not received treatment previously.
7 Remote Ischemic Conditioning (RIC) Device to Prevent Cardiac Ischemia and Infarction in Patients Undergoing Cardiac Surgery Every year, tens of thousands of Canadian patients suffer from severe cardiac ischemic injury damage caused by a restriction in the blood supply to the heart brought on by cardiac surgery or a heart attack. When blood flow to cardiac cells is disrupted and then restored, it creates a risk for a type of ischemic heart damage known as reperfusion injury. Many treatments to limit or prevent reperfusion injury have been tested. Although there has been an improvement in health care providers understanding of the processes that cause the damage, no therapies have emerged as an optimal solution to this problem. Two possible reasons for this lack of treatment success are that optimizing the timing of treatment administration is challenging, and the multitude of factors contributing to the reperfusion injury process is complex. A non-invasive automated device that may prevent or limit heart damage in patients undergoing cardiac surgery This is the first automated device to provide remote ischemic conditioning. For health care providers, it may offer a time saving compared with manually operating a standard blood pressure cuff to produce the same conditioning effect. The device has been found to significantly reduce major negative heart- and stroke-related events in patients undergoing heart surgery or suffering a heart attack. Since favourable results have been shown in many long-term studies, especially in patients who wear the cuff before surgery, the device has the strong potential to protect the heart from damage. A non-invasive automated cuff is now available that is worn on the arm or leg to temporarily stop and then restart blood flow through a series of inflations and deflations. This process is called remote ischemic conditioning. Conducted in non-critical tissue, the process can activate the body s defensive mechanisms against reperfusion injury. The cuff can be used prior to, during, or after cardiac surgery, or after an acute injury such as a heart attack. It can be applied in a hospital, in an ambulance, or at home. The device has a disposable cuff that operates in five-minute inflation and deflation cycles for a total of 40 minutes.
8 Retinal Implant to Improve Vision in Patients with Retinitis Pigmentosa Retinitis pigmentosa is a group of eye disorders involving the retina that causes slow but progressive loss of vision. It affects approximately 11,000 Canadian adults. Although the cause of retinitis pigmentosa is not known, about half of all cases are linked to a family history. There is currently no cure for retinitis pigmentosa, and no treatment to delay its progression. Vitamin supplements, dietary changes, and wearing darkened glasses may be of some benefit. A bionic eye that may restore some vision in adults with retinitis pigmentosa A new prosthetic, one that has been likened to a bionic eye, has been developed to possibly restore some vision in adult patients with retinitis pigmentosa and severe sight impairment. The prosthetic retina is surgically attached to the back of the eye in patients who have some remaining light perception and nerve function in the eye. The implant electrically stimulates the retina in order to produce light perception. It is attached externally to a camera and video-processing unit through a cable connected to a pair of glasses worn by the patient. The device has the potential to restore some level of vision and improve patients independence and mobility, although proof of its long-term effects is not available. Studies have shown that patients who received the implant had improved performance in distinguishing motion, recognizing letters, and perceiving colours. The cost of the device and its surgical implantation is estimated to be US$115,000, with some additional associated costs, such as patient and health care provider training and support. It is suggested, however, that these costs would be outweighed because of potential savings related to reduced patient need for social care and support services.
9 Self-Expanding, Drug-Coated Stent for the Treatment of Peripheral Arterial Disease The superficial femoral artery (SFA) is a long vessel in the thigh that carries blood and oxygen to the leg. This artery is a frequent site of vascular blockage due to the deposition of fatty plaques (atherosclerosis), inflammation, or blood clots. The narrowing or occlusion of this artery can cause pain or discomfort in leg muscles when the person walks, due to reduced blood flow. This condition can be debilitating and can prevent patients from working and performing daily tasks. The condition is more common in the elderly, smokers and diabetic patients. Its frequency rate is reported to be 4% in Canadians older than 40, and this number increases to 20% in people older than 75. In addition to lifestyle changes and medications to manage underlying disorders, angioplasty and stenting or surgical procedures might be recommended in some cases. Angioplasty is a less invasive procedure where a catheter is inserted through a small puncture over an artery in the patient s arm or groin and guided to the blocked area. Once in place, a special balloon, which is attached to the catheter, is inflated and deflated several times to widen the vessel and allow the blood to flow. A tiny mesh-metal tube, called a stent, is often inserted into the narrowed area to hold the vessel open. In surgical revascularization, a graft (made from one of the patient s veins or from man-made materials) is used to create a detour around the narrowed or blocked area of the leg artery. A new self-expanding, drug-eluting stent for peripheral artery disease of the superficial femoral artery An important advancement in the treatment of SFA occlusion has been the introduction of a stent that is coated with a drug to help prevent the artery from narrowing again. This drug-eluting stent is the first stent indicated for use in the SFA. It is made of a material that is self-expanding and that returns to its original shape after external pressures are removed. Its external surface is coated with a drug named paclitaxel to prevent the artery from narrowing again. Drug-eluting stents have been shown to reduce re-occlusion rates by 50% and reduce surgical re-intervention rates significantly, when compared with regular (uncoated) metal stents. The use of drug-eluting stents for the treatment of SFA occlusion can potentially lead to an improvement in quality of life, as well as higher cost savings in public health care due to fewer reocclusions and a reduced need for repeated therapeutic interventions.
10 Trastuzumab Emtansine (T DM1) for HER2-Positive Metastatic Breast Cancer Breast cancer is the most frequent cancer and the leading cause of cancer-related death among women worldwide. In Canada, breast cancer is the second-leading cause of death in women. Every day in Canada, approximately 65 women are diagnosed with breast cancer and 14 women die because of the disease. A specific protein called human epidermal growth factor receptor 2 (HER2) may be found in large amounts on the surface of some cancer cells. Women with breast cancer who are in an advanced stage of the disease, and who test positive for the HER2 gene, experience an aggressive form of the cancer and have shorter survival. Approximately one in five patients diagnosed with breast cancer will have HER2-positive disease. Chemotherapy is the standard treatment for advanced breast cancer. This type of treatment involves the use of chemotherapy to stop the growth of cancer cells, either by stopping them from dividing or by killing them. Combining HER2-targeting medicines with standard chemotherapy is an effective therapeutic approach for patients with HER2-positive advanced breast cancer. T-DM1 is a novel, targeted therapy for the treatment of HER2-positive advanced breast cancer The introduction of trastuzumab emtansine (T-DM1) provides an alternative treatment option for patients with HER2-positive advanced breast cancer who have been previously treated with trastuzumab (an anti-her2 treatment) and a taxane (a form of chemotherapy). T-DM1 is a single agent that incorporates three components: an anti-her2 agent (trastuzumab) that recognizes and attaches to HER2 receptors, a stable linker, and an anti-cancer substance (DM1). T-DM1 allows drug delivery specifically to HER2- cancer cells, thereby minimizing the exposure of normal cells to therapy. When compared with standard treatment, clinical evidence suggests that T-DM1 alone can prolong the chance of living without disease progression, improve a patient s overall survival by 5.8 months, and lower adverse events. It potentially improves health-related quality of life. This targeted approach allows for greater efficacy and lowered toxicity, compared with standard treatment.
11 Tympanostomy Tube Insertion Delivery System for Children With Chronic Ear Infections Middle ear infections are one of the most common childhood illnesses, with 75% of children having at least one episode by one year of age. Though ear infections are usually not serious, many children suffer from frequent infections, especially between six months and five years of age. Ear infections result in pain, anxiety, loss of sleep, and numerous doctors visits for the children and their caregivers. Generally, a child with frequent and persistent middle ear infections is referred to an ear, nose, and throat surgeon. The surgeon inserts a tympanostomy tube into the eardrum to equalize the air pressure in the middle ear and help drain any fluid. The procedure usually requires general anesthesia. Although there is some controversy surrounding whether inserting a tympanostomy tube improves a child s long-term development, it remains one of the most common same-day surgeries performed on children in Canada and has a significant cost impact on the health care system. An integrated in-office tube delivery system to treat children with chronic ear infections A new, integrated in-office tube-delivery system may provide an alternative to conventional surgery. The device combines the administration of a local anesthetic with tube delivery. Ten minutes after administering the anesthetic, the tube-delivery system makes a rapid incision in the eardrum and deploys a tube into the ear in a single, automated motion. Successful insertion rates for the new system are comparable to conventional surgery, though long-term follow-up information is not available. The new in-office tube-delivery system may offer fewer risks compared with conventional surgery because it eliminates the need for general anesthesia. It may also remove the costs and wait times associated with the use of general anesthetic in conventional surgery. The new procedure should be tolerated by most pediatric patients, as published evidence suggests the average level of pain felt during the in-office procedure was minimal. The impact of this technology on the volume of surgeries currently being performed in Canada and the associated wait times is unknown; however, since the wait time between referral and treatment with conventional surgery is approximately five months, the impact of the tube-delivery system should be favourable.
INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS Description of Treatment A major difficulty in treating
All men should know they are having a PSA test and be informed of the implications prior to testing. This booklet was created to help primary care providers offer men information about the risks and benefits
A WorkLife4You Guide Heart Attack: What You Need to Know What is a Heart Attack? The heart works 24 hours a day, pumping oxygen and nutrient-rich blood to the body. Blood is supplied to the heart through
Kidney Transplant Candidate Informed Consent Education Here are educational materials about Kidney Transplant. Please review and read these before your evaluation visit. The RN Transplant Coordinator will
PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION This booklet was designed to help you and the important people in your life understand the treatment of high dose chemotherapy with stem cell support: a procedure
Avastin in breast cancer: Summary of clinical data Worldwide, over one million people are diagnosed with breast cancer every year 1. It is the most frequently diagnosed cancer in women 1,2, and the leading
Understanding Coronary Artery Disease, Cardiac Catheterization, and Treatment Options A Guide for Patients Coronary Artery Disease If you or a member of your family has been diagnosed with coronary artery
VI: 2 ELEMENTS FOR A PUBLIC SUMMARY Bicalutamide (CASODEX 1 ) is a hormonal therapy anticancer agent, used for the treatment of prostate cancer. Hormones are chemical messengers that help to control the
Treatment Options for Kidney Disease: Making a choice that is best for you. 3 This booklet covers: - Types of Dialysis - Kidney Transplant - You can take control PATIENT FIRST Which Treatment Will Help
Blepharoplasty - Eyelid Surgery Introduction Eyelid surgery repairs sagging or drooping eyelids. The surgery is also known as blepharoplasty, or an eyelid lift. Sagging or drooping eyelids happen naturally
UW MEDICINE PATIENT EDUCATION Aortic Stenosis Causes, symptoms, diagnosis, and treatment This handout describes aortic stenosis, a narrowing of the aortic valve in your heart. It also explains how this
Renal cell cancer Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney. Renal cell cancer (also called kidney cancer or renal adenocarcinoma) is a disease in which
Key Facts about Influenza (Flu) & Flu Vaccine mouths or noses of people who are nearby. Less often, a person might also get flu by touching a surface or object that has flu virus on it and then touching
Page 1 Cardiac Catheterization What Other Terms Are Used To Describe Cardiac Catheterization? Heart Cath (catheter) Angiogram What Is Cardiac Catheterization? This procedure is nonsurgical and is performed
We have made the following changes to the Critical Illness events covered under our group critical illness policy. March 2015 Because everyone needs a back-up plan 7 New critical illness events added to
YOUR TREATMENT TEAM CARDIOLOGIST What does a cardiologist do? A cardiologist is a doctor who specializes in caring for your heart and blood vessel health. To become a cardiologist, a doctor completes additional
Non-Small Cell Lung Cancer Recruiting now AstraZeneca is looking for men and women with locally advanced or metastatic non-small cell lung cancer (NSCLC) to join ATLANTIC, a clinical study to help investigate
Basics of Cancer Treatment Module 6 Basics of Cancer Treatment Target Audience: Community members Staff of Indian health programs, including Community Health Representatives Contents of Learning Module:
A Patient s Guide to Minimally Invasive Abdominal Aortic Aneurysm Repair Table of Contents The AFX Endovascular AAA System............................................ 1 What is an Abdominal Aortic Aneurysm
Update in Hematology Oncology Targeted Therapies Mark Holguin 25 years ago Why I chose oncology People How to help people with possibly the most difficult thing they may have to deal with Science Turning
You ve protected your family s financial future by purchasing life and health insurance. Critical Illness Supplemental Insurance It s cash when you need it. You choose how to spend it. So you can focus
Produced 28.02.2011 Due for revision 28.02.2013 Treatment of low-grade non-hodgkin lymphoma Lymphomas are described as low grade if the cells appear to be dividing slowly. There are several kinds of low-grade
An Introduction to PROSTATE CANCER Being diagnosed with prostate cancer can be a life-altering experience. It requires making some very difficult decisions about treatments that can affect not only the
Blood & Marrow Transplant Glossary Pediatric Blood and Marrow Transplant Program Patient Guide Glossary Absolute Neutrophil Count (ANC) -- Also called "absolute granulocyte count" amount of white blood
X-Plain Chemotherapy for Breast Cancer - Adriamycin, Cytoxan, and Tamoxifen Reference Summary Introduction Breast cancer is a common condition that affects one out of every 11 women. Your doctor has recommended
GENERAL HEART DISEASE KNOW THE FACTS WHAT IS Heart disease is a broad term meaning any disease affecting the heart. It is commonly used to refer to coronary heart disease (CHD), a more specific term to
Brain Cancer Introduction Brain tumors are not rare. Thousands of people are diagnosed every year with tumors of the brain and the rest of the nervous system. The diagnosis and treatment of brain tumors
Multiple Myeloma Introduction Multiple myeloma is a type of cancer that affects white blood cells. Each year, thousands of people find out that they have multiple myeloma. This reference summary will help
1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT Learning that your pet has a diagnosis of cancer can be overwhelming. We realize that your pet
UW MEDICINE PATIENT EDUCATION Cardiac Catheterization Lab Procedures This handout describes how cardiac catheterization works. It also explains how to prepare for your procedure and the self-care needed
CHAPTER 1 NORMAL VENOUS CIRCULATION Original author: Frank Padberg Abstracted by Teresa L.Carman Introduction The circulatory system is responsible for circulating (moving) blood throughout the body. The
Write questions or notes here: Level 1, 131-135 Summer Street ORANGE NSW 2800 Ph: 02 63631688 Fax: 02 63631865 Document Title: Revision Total Hip Replacement Further Information and Feedback: Tell us how
Bile Duct Diseases and Problems Introduction A bile duct is a tube that carries bile between the liver and gallbladder and the intestine. Bile is a substance made by the liver that helps with digestion.
FAQ About Prostate Cancer Treatment and SpaceOAR System P. 4 Prostate Cancer Background SpaceOAR Frequently Asked Questions (FAQ) 1. What is prostate cancer? The vast majority of prostate cancers develop
You ve protected your family s financial future by purchasing life and health insurance. Critical Illness Insurance It s cash when you need it. You choose how to spend it. So you can focus on getting well.
Useful information for cancer patients Contents This information is an overview of treatments for primary liver cancer. There are sections on Primary or secondary cancer The main treatments for primary
Prostate Cancer Screening A Decision Guide for African Americans This booklet was developed by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). Published
X-Plain Varicose Veins Reference Summary Introduction Varicose veins are very common, in both women and men. Varicose veins can be painful and unattractive. Vein doctors use non-invasive ultrasound imaging
You ve protected your family s financial future by purchasing life and health insurance. Critical Illness Insurance It s cash when you need it. You choose how to spend it. So you can focus on getting well.
Radiation Therapy for Prostate Cancer Introduction Cancer of the prostate is the most common form of cancer that affects men. About 240,000 American men are diagnosed with prostate cancer every year. Your
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
Cardiac catheterization Information for patients You have been scheduled for a cardiac catheterization. Your procedure is scheduled for:. Someone will call you the day before your procedure to tell you
Facts About Peripheral Arterial Disease (P.A.D.) One in every 20 Americans over the age of 50 has P.A.D., a condition that raises the risk for heart attack and stroke. Peripheral arterial disease, or P.A.D.,
Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses
Blood Transfusion Introduction Blood transfusions can save lives. Every second, someone in the world needs a blood transfusion. Blood transfusions can replace the blood lost from a serious injury or surgery.
Kidney Disease WHAT IS KIDNEY DISEASE? Kidney disease is when your kidneys are damaged and not functioning as they should. When kidney disease is not going away it is called chronic kidney disease or CKD.
Avastin in breast cancer: Summary of clinical data Worldwide, over one million people are diagnosed with breast cancer every year 1. It is the most frequently diagnosed cancer in women 1,2, and the leading
Acute myeloid leukemia (AML) Adult acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes abnormal myeloblasts (a type of white blood cell), red blood cells, or platelets. Adult
PATIENT INFORMATION BOOKLET Wingspan Stent System with Gateway PTA Balloon Catheter TABLE OF CONTENTS Definitions... 2 What is the Purpose of This Booklet?... 3 What is an Intracranial Lesion?... 3 Who
Thymus Cancer Introduction Thymus cancer is a rare cancer. It starts in the small organ that lies in the upper chest under the breastbone. The thymus makes white blood cells that protect the body against
Treating Melanoma Skin Cancer A Quick Guide Contents This is a brief summary of the information on Treating melanoma skin cancer from our website. You will find more detailed information on the website.
Stem Cell Quick Guide: Stem Cell Basics What is a Stem Cell? Stem cells are the starting point from which the rest of the body grows. The adult human body is made up of hundreds of millions of different
National MS Society Information Sourcebook www.nationalmssociety.org/sourcebook Chemotherapy The literal meaning of the term chemotherapy is to treat with a chemical agent, but the term generally refers
Exercise and Breast Cancer: Things you can do! Cancer within the fire service is one of the most dangerous threats to our firefighter s health & wellness. According to the latest studies firefighters are
RADIATION THERAPY FOR Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY FACTS ABOUT The lymphatic system is a network of tiny vessels extending
Procedure Information Guide Total hip replacement Brought to you in association with EIDO and endorsed by the The Royal College of Surgeons of England Discovery has made every effort to ensure that the
Write questions or notes here: Level 1, 131-135 Summer Street ORANGE NSW 2800 Ph: 02 63631688 Fax: 02 63631865 Document Title: Total Knee Replacement Further Information and Feedback: Tell us how useful
Prostate Cancer Screening The American Cancer Society and Congregational Health Ministry Team June Module To access this module via the Web, visit www.cancer.org and type in congregational health ministry
Multiple Myeloma Understanding your diagnosis Multiple Myeloma Understanding your diagnosis When you first hear that you have cancer you may feel alone and afraid. You may be overwhelmed by the large amount
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Bone Marrow Transplantation
Procedure Information Guide Resurfacing hip replacement Brought to you in association with EIDO and endorsed by the The Royal College of Surgeons of England Discovery has made every effort to ensure that
Blood Transfusion Introduction Blood transfusions are very common. Each year, almost 5 million Americans need a blood transfusion. Blood transfusions are given to replace blood lost during surgery or serious
Acute Myeloid Leukemia Introduction Leukemia is cancer of the white blood cells. The increased number of these cells leads to overcrowding of healthy blood cells. As a result, the healthy cells are not
What is Balloon Sinuplasty? The painful symptoms associated with chronic sinusitis can be overwhelming. If symptoms are difficult to control with medications alone, your primary doctor may refer you to
Treatments to Restore Normal Rhythm In many instances when AF causes significant symptoms or is negatively impacting a patient's health, the major goal of treatment is to restore normal rhythm and prevent
Understanding your Renal Stent Procedure. A patient Guide (COVER PAGE) TABLE OF CONTENTS (inside front page) The Kidney and the Renal Arteries... 1 Renal Artery Disease... 2 Diagnosis of Renal.Artery Disease...
Low Blood Pressure Introduction Low blood pressure, or hypotension, is when your blood pressure reading is 90/60 or lower. Some people have low blood pressure all of the time. In other people, blood pressure
JULY 2007 Incorporates published evidence to November 2006 INFORMATION ABOUT Trastuzumab (Herceptin ) for patients with metastatic breast cancer This information has been developed to help you understand
Quality Measures for Long-stay Residents Percent of residents whose need for help with daily activities has increased. This graph shows the percent of residents whose need for help doing basic daily tasks
Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation PATIENT EDUCATION GUIDE What is atrial fibrillation? Atrial fibrillation
Blood-Forming Stem Cell Transplants What are bone marrow and hematopoietic stem cells? Bone marrow is the soft, sponge-like material found inside bones. It contains immature cells known as hematopoietic
Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Areas to be covered Historical, current, and future treatments for various cardiovascular disease: Atherosclerosis (Coronary
Treatment Guide Lung Cancer Management The Chest Cancer Center at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute and Miller Family Heart & Vascular
Cardiac Catheter Lab Information for patients having a Coronary Angiogram Page 1 of 5 What is a Coronary Angiogram? This is a test that uses dye and special x-rays to show the inside of your coronary arteries.
Y O U R S U R G E O N S choice of implants F O R Y O U R S U R G E R Y Y O U R S U R G E O N S choice of implants F O R Y O U R S U R G E R Y Your Surgeon Has Chosen the C 2 a-taper Acetabular System The
Issue date August 2009 Understanding NICE guidance Information for people who use NHS services Image-guided mitral leaflet repair for mitral regurgitation NICE interventional procedures guidance advises
Listen to Your Heart The S-ICD System What Everyone Needs To Know About Atrial Fibrillation & Stroke The protection you need without Stroke. touching Are you your at heart risk? Increase your knowledge.
Faculty Prevention Sharon Ewer, RN, BSN, CNRN Stroke Program Coordinator Baptist Health Montgomery, Alabama Satellite Conference and Live Webcast Monday, May 21, 2012 2:00 4:00 p.m. Central Time Produced
Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease 1 Produced by St. Jude Children s Research Hospital Departments of Hematology, Patient
Lifecheque Basic Critical Illness Insurance Strong. Reliable. Trustworthy. Forward-thinking. Extra help on the road to recovery Surviving a critical illness can be very challenging financially Few of us
Inferior Vena Cava filter and removal What is Inferior Vena Cava Filter Placement and Removal? An inferior vena cava filter placement procedure involves an interventional radiologist (a specialist doctor)
Treating Mesothelioma - A Quick Guide Contents This is a brief summary of the information on Treating mesothelioma from CancerHelp UK. You will find more detailed information on the website. In this information
X-Plain Diabetes - Introduction Reference Summary Introduction Diabetes is a disease that affects millions of Americans every year. Your doctor may have informed you that you have diabetes. Although there